Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review

References

• Cowling BJ, Ip DK, Fang VJ, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4(1):1935. PMID: 23736803; PMCID: PMC3682679.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Influenza. epidemiology and prevention of vaccine-preventable diseases. The Pink Book. [cited 2021 Jan 30]. Available from: https://www.cdc.gov/vaccines/pubs/pinkbook/flu.html
   Google Scholar
• Treanor JJ. Clinical practice. influenza vaccination. N Engl J Med. 2016 Sep 29;375(13):1261–1268. PMID: 27682035.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. [cited 2021 Jan 30]. Available: https://www.ecdc.europa.eu/en/seasonal-influenza/facts/factsheet.
   Google Scholar
• Caini S, Spreeuwenberg P, Kusznierz GF, et al. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999–2014. A., … Global Influenza B Study group BMC Infect Dis. 2018;181:269.
   PubMedGoogle Scholar
• Lafond KE, Nair H, Rasooly MH, et al. Global Respiratory Hospitalizations – influenza Proportion Positive (GRIPP) working group. global role and burden of influenza in pediatric respiratory hospitalizations, 1982–2012: a systematic analysis. PLoS Med. 2016;13(3):e1002060.
   PubMed Web of Science ®Google Scholar
• Koliou M, Soteriades ES, Toumasi MM, et al. Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June - August 2009. Euro Surveill. 2009 Aug 20;14(33):19312. PMID: 19712641.
   PubMedGoogle Scholar
• Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, et al. Influenza Clinical Information Network (FLU-CIN). risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: united Kingdom first wave (May-September 2009). Thorax. 2010 Jul;65(7):645–651. PMID: 20627925; PMCID: PMC2921287.
   PubMed Web of Science ®Google Scholar
• Fuhrman C, Bonmarin I, Paty AC, et al. Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill. 2010 Jan 14;15(2):19463. PMID: 20085690.
   PubMedGoogle Scholar
• Wang X, Li Y, O’Brien KL, et al. Respiratory virus global epidemiology network. global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020 Apr 8;8(4):e497–e510. Epub 2020 Feb 20. PMID: 32087815; PMCID: PMC7083228.
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007 Jun 28;25(27):5086–5096. Epub 2007 Apr 20. PMID: 17544181.
   PubMed Web of Science ®Google Scholar
• Putri WCWS, Muscatello DJ, Stockwell MS, et al. Economic burden of seasonal influenza in the United States. Vaccine. 2018 Jun 22;36(27):3960–3966. Epub 2018 May 22. PMID: 29801998.
   PubMed Web of Science ®Google Scholar
• Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26(11):911–924. PMID: 18850761.
   PubMed Web of Science ®Google Scholar
• Bleser WK, Miranda PY, Salmon DA. Child influenza vaccination and adult work loss: reduced sick leave use only in adults with paid sick leave. Am J Prev Med. 2019 Feb;56(2):251–261; Epub 2018 Dec 17. PMID: 30573337.
   PubMed Web of Science ®Google Scholar
• Van Wormer JJ, King JP, Gajewski A, et al. Influenza and workplace productivity loss in working adults. J Occup Environ Med. 2017 Dec;59(12):1135–1139. PMID: 28759481.].
   PubMed Web of Science ®Google Scholar
• Cassini A, Colzani E, Pini A, et al. On behalf of the BCoDE consortium. impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European Union and European economic area countries, 2009 to 2013. Euro Surveill. 2018 Apr;23(16):17–00454. PMID: 29692315; PMCID: PMC5915974.
   Google Scholar
• Antonova EN, Rycroft CE, Ambrose CS, et al. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health. 2012;12(1):968.
   PubMed Web of Science ®Google Scholar
• Ehlken B, Ihorst G, Lippert B, et al. PRIDE study group. economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany. Eur J Pediatr. 2005;164(10):607–615.
   PubMed Web of Science ®Google Scholar
• Esposito S, Cantarutti L, Molteni CG, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect. 2011;62(5):379–387.
   PubMed Web of Science ®Google Scholar
• Bednarczyk RA, Adjaye-Gbewonyo D, Omer SB. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol. 2012 Sep;207(3Suppl):S38–46; Epub 2012 Jul 11. PMID: 22920058.
   PubMedGoogle Scholar
• Rizzo C, Rezza G, Ricciardi W. Strategies in recommending influenza vaccination in Europe and US. Hum Vaccin Immunother. 2018 Mar 4;14(3):693–698. Epub 2018 Jan 9. PMID: 28922083; PMCID: PMC5861797.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control (ECDC). Vaccine scheduler. Influenza: recommended vaccination. [cited 2021 Jan 30]. Available from: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=15&SelectedCountryIdByDisease=−1.
   Google Scholar
• Grohskopf LA, Alyanak E, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices - United States, 2020-21 influenza season. MMWR Recomm Rep. 2020 Aug 21;69(8):1–24. PMID: 32820746; PMCID: PMC7439976.
   PubMed Web of Science ®Google Scholar
• Young K, Gemmill I, Harrison R. on behalf of the National Advisory Committee on Immunization (NACI). Summary of the NACI seasonal influenza vaccine statement for 2020–2021. Can Commun Dis Rep. 2020;46(5):132–137.
   PubMedGoogle Scholar
• National Health Service (NHS). Department of health and social care. public health England. The national flu immunisation programme 2020 to 2021- update. [cited 2021 Jan 30]. Availablefrom: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/907149/Letter_annualflu_2020_to_2021_update.pdf.
   Google Scholar
• Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine. 2005 Feb 18;23(13):1540–1548. PMID: 15694506.
   PubMed Web of Science ®Google Scholar
• Rolfes MA, Flannery B, Chung JR, et al. Effectiveness (Flu VE) network, the influenza hospitalization surveillance network, and the assessment branch, immunization services division, centers for disease control and prevention. effects of influenza vaccination in the United States during the 2017-2018 influenza season. Clin Infect Dis. 2019 Nov 13;69(11):1845–1853. PMID: 30715278; PMCID: PMC7188082.
   PubMed Web of Science ®Google Scholar
• Kalligeros M, Shehadeh F, Mylona EK, et al. Influenza vaccine effectiveness against influenza-associated hospitalization in children: a systematic review and meta-analysis. Vaccine. 2020 Mar 23;38(14):2893–2903. Epub 2020 Feb 27. PMID: 32113808.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Raviotta JM, DePasse JV, et al. Cost Effectiveness Of Influenza Vaccine Choices In Children Aged 2-8 Years in the U.S. Am J Prev Med. 2016 May;50(5):600–608; Epub 2016 Feb 8. PMID: 26868283; PMCID: PMC4841730.
   PubMed Web of Science ®Google Scholar
• Shim E, Brown ST, DePasse J, et al. Cost effectiveness of influenza vaccine for U.S. children: live attenuated and inactivated influenza vaccine. Am J Prev Med. 2016 Sep;51(3):309–317; Epub 2016 Apr 11. PMID: 27079638; PMCID: PMC5384696.
   PubMed Web of Science ®Google Scholar
• Loeb M, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA. 2010 Mar 10;303(10):943–950. PMID: 20215608.
   PubMed Web of Science ®Google Scholar
• Wang B, Russell ML, Moss L, et al. Effect of influenza vaccination of children on infection rate in hutterite communities: follow-up study of a randomized trial. PLoS One. 2016 Dec 15;11(12):e0167281. PMID: 27977707; PMCID: PMC5157992.
   PubMed Web of Science ®Google Scholar
• Gregg M, Blackhouse G, Loeb M, et al. Economic evaluation of an influenza immunization strategy of healthy children. Int J Technol Assess Health Care. 2014 Oct;30(4):394–399; Epub 2014 Nov 21. PMID: 25412647.
   PubMed Web of Science ®Google Scholar
• Pitman RJ, Nagy LD, Sculpher MJ. Cost-effectiveness of childhood influenza vaccination in England and Wales: results from a dynamic transmission model. Vaccine. 2013 Jan 30;31(6):927–942. Epub 2012 Dec 14. PMID: 23246550.
   PubMed Web of Science ®Google Scholar
• Damm O, Eichner M, Rose MA, et al. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Eur J Health Econ. 2015 Jun;16(5):471–488; Epub 2014 May 25. PMID: 24859492; PMCID: PMC4435640.
   PubMed Web of Science ®Google Scholar
• Thommes EW, Ismaila A, Chit A, et al. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. BMC Infect Dis. 2015 Oct 27;15(1):465. PMID: 26503131; PMCID: PMC4623926.
   PubMedGoogle Scholar
• Gerlier L, Lamotte M, Grenèche S, et al. Assessment of public health and economic impact of intranasal live-attenuated influenza vaccination of children in France using a dynamic transmission model. Appl Health Econ Health Policy. 2017 Apr;15(2):261–276. PMID: 27943165.
   PubMed Web of Science ®Google Scholar
• Nagy L, Heikkinen T, Sackeyfio A, et al. The clinical impact and cost effectiveness of quadrivalent versus trivalent influenza vaccination in Finland. Pharmacoeconomics. 2016 Sep;34(9):939–951. PMID: 27423657; PMCID: PMC4980401.
   PubMed Web of Science ®Google Scholar
• Thorrington D, Van Leeuwen E, Ramsay M, et al. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Med. 2017 Sep 8;15(1):166. PMID: 28882149; PMCID: PMC5590113.
   PubMed Web of Science ®Google Scholar
• De Boer PT, Backer JA, Van Hoek AJ, et al. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes. BMC Med. 2020 Jan 14;18(1):11. PMID: 31931789; PMCID: PMC6958762.
   PubMed Web of Science ®Google Scholar
• Baguelin M, Camacho A, Flasche S, et al. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med. 2015 Oct 13;13(1):236. PMID: 26459265; PMCID: PMC4604076.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Recommendations on influenza vaccination during the 2019–2020 winter season (2019). [cited 2021 Jan 30]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0017/413270/Influenza-vaccine-recommendations-2019-2020_en.pdf.
   Google Scholar
• Regional Office for Europe World Health Organization (WHO). WHO recommendations on influenza vaccination for the 2020/2021 season during the ongoing COVID-19 pandemic (2020). [cited 2021 Jan 30]. Availablefrom: https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/who-regional-office-for-europe-recommendations-on-influenza-vaccination-for-the-20202021-season-during-the-ongoing-covid-19-pandemic-2020.
   Google Scholar
• Pellegrinelli L, Bubba L, Galli C, et al. Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010-2017). J Gen Virol. 2017 Nov;98(11):2699–2711. PMID: 29106347.
   PubMed Web of Science ®Google Scholar
• Taylor S, Lopez P, Weckx L, et al. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Infect. 2017 Jan;74(1):29–41; Epub 2016 Sep 22. PMID: 27667752; PMCID: PMC7112512.
   PubMed Web of Science ®Google Scholar
• GOV.UK. annual flu programme. [cited 2021 Jan 30]. Availablefrom: https://www.gov.uk/government/collections/annual-flu-programme#2020-to-2021-flu-season.
   Google Scholar
• Pebody R, Warburton F, Andrews N, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20(36). DOI:https://doi.org/10.2807/1560-7917.ES.2015.20.36.30013 PMID: 26535911.
   Google Scholar
• Pebody R, Warburton F, Ellis J, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 mid-season results. Euro Surveill. 2016;21(13). DOI:https://doi.org/10.2807/1560-7917.ES.2016.21.13.30179 PMID: 27074651.
   Google Scholar
• Pebody R, Sile B, Warburton F, et al. Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season. Euro Surveill. 2017 Jan 26;22(4):30450. PMID: 28182539; PMCID: PMC5388092.
   PubMedGoogle Scholar
• Pebody RG, Green HK, Andrews N, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15. Euro Surveill. 2015;20(39). https://doi.org/10.2807/1560-7917.ES.2015.20.39.30029 PMID: 26537222.
   Google Scholar
• Pebody R, Warburton F, Ellis J, et al. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveill. 2017 Nov;22(44):17–00306. PMID: 29113630; PMCID: PMC5710133.
   Google Scholar
• Sugaya N. A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in Japan. Expert Rev Vaccines. 2014 Dec;13(12):1563–1570. Epub 2014 Aug 20. PMID: 25138431.
   PubMed Web of Science ®Google Scholar
• Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001 Mar 22;344(12):889–896. PMID: 11259722.
   PubMed Web of Science ®Google Scholar
• Charu V, Viboud C, Simonsen L, et al. Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS One. 2011;6(11):e26282. Epub 2011 Nov 7. PMID: 22087226; PMCID: PMC3210121.
   PubMed Web of Science ®Google Scholar
• Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine. 2011 Oct 6;29(43):7554–7558. PMID: 21820477. Epub 2011 Aug 4.
   PubMed Web of Science ®Google Scholar
• Newall AT, Jit M, Beutels P. Economic evaluations of childhood influenza vaccination: a critical review. Pharmacoeconomics. 2012 Aug 1;30(8):647–660. PMID: 22788257.
   PubMed Web of Science ®Google Scholar